Peptide Receipt
Tesamorelin · Checked 2026-07-25
PR-DRAFT-MS0L8LTI-2Q5F5M1A
Claim
“Tesamorelin burns visceral fat”
What people report
Anecdotal · Unverifiedvisceral fat reduction · growth hormone stimulation · HIV lipodystrophy context
Some people report benefits and others describe concerns or side effects. Experiences vary, and none of this determined the verdict below.
Research
Mostly Supported
Confidence · High
Yes, Tesamorelin is specifically designed and FDA-approved to reduce visceral fat (the deep 'belly fat' around organs). However, this approval and most research only apply to people living with HIV who have lipodystrophy. It is not approved or well-studied as a general-purpose weight loss drug for the average person.
Evidence
- Human
- Strong
- Animal
- None
- Lab
- None
- Registered trials
- 1
Sources
Research and educational information only. Not medical advice.